STRO
Sutro Biopharma
16.10$
-1.3%
vs. previous close
Closing price · As of: Sep 22, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 72.9% | 100.3% | 141.2% | 153.5% | 180.1% | 15.8% | 12.2% | 4.4% | 11.6% | 7.1% | |
| 27.1% | -0.3% | -41.2% | 100.0% | -80.1% | 84.2% | 87.8% | 95.6% | 88.4% | 92.9% | |
| 72.9% | 105.6% | 141.2% | 153.5% | 180.1% | 168.7% | 202.4% | 117.4% | 406.2% | 162.4% | |
| 24.8% | 31.6% | 55.6% | 76.3% | 86.2% | 90.5% | 87.9% | 40.7% | 78.1% | 40.0% | |
| 97.7% | 137.2% | 196.9% | 229.8% | 86.2% | 243.4% | 278.0% | 153.6% | 472.7% | 195.3% | |
| 2.3% | -37.2% | -96.9% | -129.8% | -166.3% | -159.2% | -190.3% | -58.1% | -384.3% | -102.4% | |
| 0.0% | 1.3% | 4.2% | 10.2% | 9.3% | 5.1% | 4.9% | 15.4% | 50.1% | 37.3% | |
| 2.8% | -38.1% | -91.9% | -130.4% | -75.2% | -170.6% | -172.2% | -57.6% | -362.8% | -186.5% | |
| 0.1% | 1.0% | 9.2% | 20.3% | 9.5% | 5.1% | 3.7% | 11.8% | 3.8% | -0.1% | |
| 2.8% | -38.1% | -91.9% | -130.4% | -75.2% | -170.6% | -175.9% | -69.5% | -366.6% | -186.5% | |
| 12.3% | -27.2% | -85.4% | -109.1% | -55.6% | -157.7% | -155.0% | -44.2% | -290.9% | -142.1% |
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.